2004•Zhiye yu jiankangRequires access

Surveillance on measles antibody level in healthy population and serological effect of intensive immunization with measles vaccine

LI Yong-jun

Open publisher page 0 citations

Abstract

Objective To study the effect of intensive immunization with measles vaccine and the measles antibody level in healthy population. [Methods] ELISA was adopted to detect the measles IgG-antibody of the randomly selected 1 534 healthy people between the age of 0 to 39 from 2 counties. [Results] The antibody positive rate was 77.57% (1 190/1 534); GMT was 1:783. The antibody positive rate was the highest among children between the age of 1 to 12 (85.71%~98.44%). GMT began to descend to middle and low level from 6 years old. The antibody positive rate showed a decreasing tendency along with the increase of age. The success rate of the first vaccination on 188 children aged from 8~12 months was 96.81%; the success rate of revaccination on 186 children aged from 5~7 years old was 61.29%; The GMT after the first and second vaccination increased by 28.4 and 3.1 times respectively. [Conclusion] The measles antibody level of older children and adults can only reach the middle and low level. Whether in the first vaccination or revaccination, those whose antibody was in middle and low level may have a significantly higher success rate than those with high level of antibody.

About this research paper

What this paper is about

Objective To study the effect of intensive immunization with measles vaccine and the measles antibody level in healthy population. [Methods] ELISA was adopted to detect the measles IgG-antibody of the randomly selected 1 534 healthy people between the age of 0 to 39 from 2 counties. [Results] The antibody positive rate was 77.57% (1 190/1 534); GMT was 1:783. The antibody positive rate was the highest among children between the age of 1 to 12 (85.71%~98.44%). GMT began to descend to middle and low level from 6 years old. The antibody positive rate showed a decreasing tendency along with the increase of age. The success rate of the first vaccination on 188 children aged from 8~12 months was 96.81%; the success rate of revaccination on 186 children aged from 5~7 years old was 61.29%; The GMT after the first and second vaccination increased by 28.4 and 3.1 times respectively. [Conclusion] The measles antibody level of older children and adults can only reach the middle and low level. Whether in the first vaccination or revaccination, those whose antibody was in middle and low level may have a significantly higher success rate than those with high level of antibody.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the effect of intensive immunization with measles vaccine and the measles antibody level in healthy population. [Methods] ELISA was adopted to detect the measles IgG-antibody of the randomly selected 1 534 healthy people between the age of 0 to 39 from 2 counties. [Results] The antibody positive rate was 77.57% (1 190/1 534); GMT was 1:783. The antibody positive rate was the highest among children between the age of 1 to 12 (85.71%~98.44%). GMT began to descend to middle and low level from 6 years old. The antibody positive rate showed a decreasing tendency along with the increase of age. The success rate of the first vaccination on 188 children aged from 8~12 months was 96.81%; the success rate of revaccination on 186 children aged from 5~7 years old was 61.29%; The GMT after the first and second vaccination increased by 28.4 and 3.1 times respectively. [Conclusion] The measles antibody level of older children and adults can only reach the middle and low level. Whether in the first vaccination or revaccination, those whose antibody was in middle and low level may have a significantly higher success rate than those with high level of antibody.

Key concepts: Measles, Medicine, Vaccination, Immunization, Antibody, Measles vaccine, Serology, Population

Related papers

Back to paper searchBrowse research topicsOriginal source
Surveillance on measles antibody level in healthy population and serological effect of intensive immunization with measles vaccine — Research Paper | ScholarLens